2023-04-01 2024-03-31 false Capium Accounts Production 1.1 09504073 2023-04-01 2024-03-31 09504073 bus:AbridgedAccounts 2023-04-01 2024-03-31 09504073 bus:FRS102 2023-04-01 2024-03-31 09504073 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 09504073 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 09504073 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 09504073 2023-04-01 2024-03-31 09504073 2024-03-31 09504073 bus:RegisteredOffice 2023-04-01 2024-03-31 09504073 core:WithinOneYear 2024-03-31 09504073 core:AfterOneYear 2024-03-31 09504073 1 2023-04-01 2024-03-31 09504073 bus:Director1 2023-04-01 2024-03-31 09504073 bus:Director1 2024-03-31 09504073 bus:Director1 2022-04-01 2023-03-30 09504073 2022-04-01 09504073 bus:CompanySecretary1 2023-04-01 2024-03-31 09504073 bus:LeadAgentIfApplicable 2023-04-01 2024-03-31 09504073 2022-04-01 2023-03-30 09504073 2023-03-30 09504073 core:WithinOneYear 2023-03-30 09504073 core:AfterOneYear 2023-03-30 09504073 bus:EntityAccountantsOrAuditors 2022-04-01 2023-03-30 09504073 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 09504073 bus:OrdinaryShareClass1 2024-03-31 09504073 bus:OrdinaryShareClass1 2022-04-01 2023-03-30 09504073 bus:OrdinaryShareClass1 2023-03-30 09504073 core:ComputerEquipment 2023-04-01 2024-03-31 09504073 core:ComputerEquipment 2024-03-31 09504073 core:ComputerEquipment 2023-03-30 09504073 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-03-31 09504073 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-03-30 09504073 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 09504073 core:CostValuation core:Non-currentFinancialInstruments 2023-03-30 09504073 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-03-31 09504073 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-03-31 09504073 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-03-31 09504073 core:Non-currentFinancialInstruments 2024-03-31 09504073 core:Non-currentFinancialInstruments 2023-03-30 09504073 core:CapitalRedemptionReserve 2024-03-31 09504073 core:CapitalRedemptionReserve 2023-03-30 09504073 core:RetainedEarningsAccumulatedLosses 2024-03-31 09504073 core:RetainedEarningsAccumulatedLosses 2023-03-30 09504073 dpl:Item1 2023-04-01 09504073 dpl:Item1 2024-03-31 09504073 dpl:Item1 2022-04-01 09504073 dpl:Item1 2023-03-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 09504073
England and Wales

 

 

 

IMPRESS HEALTHCARE LTD


Abridged Accounts
 


Period of accounts

Start date: 01 April 2023

End date: 31 March 2024
Accountants report:  You consider that the company is exempt from an audit for the year ended 31 March 2024. You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
Paul Ebhodaghe Ono
Chartered Accountant 



....................................................
PAUL ONO
CPPT & ACCOUNTANCY SERVICES LIMITED

UNIT 203A
ISLAND BUSINESS CENTRE
18 - 36 WELLINGTON STREET
LONDON
SE18 6PF
07 February 2025
1
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 6 2,000   
2,000   
Current assets      
Debtors 162    105 
Creditors: amount falling due within one year 8,762   
Net current assets 8,924    105 
 
Total assets less current liabilities 10,924    105 
Creditors: amount falling due after more than one year (30,834)  
Net assets (19,910)   105 
 

Capital and reserves
     
Capital Redemption Reserve (20,840)   (745)
Profit and loss account 930    850 
Shareholders' funds (19,910)   105 
 


For the accounting period ended 31 March 2024, the company was entitled to exemption from audit under section 477 of the companies act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the financial year ended 31 March 2024 in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the companies act 2006 with respect to accounting records and the preparation of accounts for the financial year ended 31 March 2024.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 06 February 2025 and were signed by:


-------------------------------
MARGARET NGIGI MUMBI
Director
2
General Information
The Impress Healthcare Ltd is a Private Limited Company which was incorporated in England and Wales on 23 March 2015. The Registered Office Address of the company is:  2 Cocksmead Croft, Kings Heath, Birmingham, West Midlands, B14 6PR, United Kingdom. The registration number of the company is 09504073.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements for the financial year ended 31 March 2024 have been prepared in compliance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared on the going concern basis and under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover is measured at the fair value of the consideration received or receivable from third parties for the financial year ended 31 March 2024, excluding discounts, rebates, value added tax and other sale taxes.

Cost of sales
Cost of sales Cost of Sales represents the cost of services rendered to third parties during the financial year period ended 31 March 2024.
Intangible assets
Intangible assets for the financial year ended 31 March 2024 (including purchased goodwill and patents) are amortised at rates at 25% calculated to write off the assets on a straight line basis over their estimated useful economic lives of 4 years. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable.

Computer software development costs
Development costs of computer software are capitalised once a detailed program design has been established and are amortised on a straight line basis over 5 years.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis: Computer, Printer and Laptop at the cost of £2500 and 20% Straight Line for over 5 years - reducing Balance.

Computer Equipment, Laptop and Printer 20% /4 years Reducing Balance
2.

Directors' Emoluments

2024
£
  2023
£
Administrative Expenses
Directors Salaries 18,000   
Directors Fees 4,000   
22,000   
 
Number of directors to whom retirement benefits accrued Number   Number
Defined contribution plans 1    1 
Defined benefit plans 1    1 
 The director's pay and other emoluments are part of total staff costs during the financial year ended 31 March 2024. 

3.

Staff Costs

2024
£
  2023
£
Wages and salaries 18,000    9,000 
Other staff costs 800    1,010 
18,800    10,010 
 
Average number of employees during the year Number   Number
Administration 1    1 
 
 The employees and casual staff of the company are paid through Pay As You Earn and through a compliant Payroll  system during the financial year period ended 31 March 2024. 

4.

Average number of employees

The Average number of employees for the financial year ended 31 March 2024 was: 1
Average number of employees during the year was 1 (2023 : 1).
5.

Financial Commitments, Guarantees and Contingencies

The Director of the company is committed and dedicated to ensuring that the business continue to be a success story and will continue to support it with the necessary funds and acquired skills to take the business to the next level. 

6.

Tangible fixed assets

Cost or valuation Computer Equipment, Laptop and Printer   Total
  £   £
At 01 April 2023 2,500    2,500 
Additions  
Disposals  
At 31 March 2024 2,500    2,500 
Depreciation
At 01 April 2023  
Charge for year 500    500 
On disposals  
At 31 March 2024 500    500 
Net book values
Closing balance as at 31 March 2024 2,000    2,000 
Opening balance as at 01 April 2023  


7.

Share Capital

Authorised
100 Class A shares of £1.00 each
Allotted, called up and fully paid
2024
£
  2023
£
100 Class A shares of £1.00 each 100    100 
100    100 

8.

Advances and Credits



BOUNCE BACK LOAN & REPAYMENT
THE DIRECTOR OF IMPRESS HEALTHCARE TAKES OUT A BOUNCE BACK LOAN FOR A SIX YEAR TERM ON 1 MAY 2020. THERE IS AUTOMATICALLY ONE YEAR WITH NO PAYMENTS OR INTEREST AND THE BUSINESS INTERRUPTION PAYMENT IS £1,250 (£50,000 X 2.5%). Repayment of another financial year ended 31 March 2024 was £887.37 PER MONTH OR £10,648 PER financial year ended 31 March 2024. THE LOAN IS PROFILED USING THE AMORTISED COST METHOD.

Current year (2024)
Brought Forward
£
Amount
£
Interest
£
Repaid
£
Written Off
£
Waived
£
Carry Forward
£
BOUNCE BACK LOAN & REPAYMENT40,417 1,065 10,648 30,834 
4041701065106480030834
Previous year (2023)
Brought Forward
£
Amount
£
Interest
£
Repaid
£
Written Off
£
Waived
£
Carry Forward
£
BOUNCE BACK LOAN & REPAYMENT50,000 1,065 10,648 40,417 
5000001065106480040417
3